| Literature DB >> 35049108 |
Guang Li1, Wei Lu1, Kyle O'Grady1, Iris Yan1, Ellen Yorke1, Laura I Cervino Arriba1, Simon Powell2, Linda Hong1.
Abstract
PURPOSE: We share our experiences on uniformly implementing an effective and efficient SGRT procedure with a new clinical workflow for treating breast patients in deep-inspiration breath-hold (DIBH) among 9 clinical centers using 26 optical surface imaging (OSI) systems.Entities:
Keywords: deep-inspiration breast hold (DIBH); left-sided breast radiotherapy; optical surface imaging (OSI); surface-guided radiotherapy (SGRT)
Mesh:
Year: 2022 PMID: 35049108 PMCID: PMC8906224 DOI: 10.1002/acm2.13511
Source DB: PubMed Journal: J Appl Clin Med Phys ISSN: 1526-9914 Impact factor: 2.102
FIGURE 1A uniform clinical workflow for surface‐guided radiotherapy (SGRT) treatment for breast cancer patients using the deep‐inspiration breath‐hold (DIBH) method. (a) First setup the patient at free‐breathing (FB) using the two‐step setup strategy to align the arm/chin first and then breast region of interest (ROI), (b) setup patient at DIBH, including the option of bolus placing and X‐ray imaging, and (c) deliver the treatment at DIBH with the motion management interface (MMI) for beam control. Note that a new on‐site reference is always captured regardless of imaging or bolus conditions before DIBH treatment
FIGURE 2Breast region of interest (ROI) definitions for whole‐breast treatments: (a) the ROI in left‐sided native breast treatment and (b) the ROI for right‐sided implanted breast treatment. The breast deep‐inspiration breath‐hold (DIBH) surface‐guided radiotherapy (SGRT) procedure is mostly applied to treat left‐sided breast patients but is also used to treat right‐sided breast patients in our institution
FIGURE 3An example of breast deformation caused by arm position variation for a partial breast irradiation (PBI) patient. The tumor‐bed volume (blue), planning tumor volume (red), beam aperture (yellow), and simulation body contour (green) are shown. (a) A good arm alignment allows a good breast alignment between the setup portal image (pink) and the body contour (green) in the digitally reconstructed radiograph (DRR) of simulation computed tomography (CT) and (b) somewhat deformed breast near the tumor bed (green and pink arrows in b) when the arm (green and pink arrows in b) is misaligned by ∼1 cm in the beam eye's view
FIGURE 4Illustration of the arm alignment of a locally advanced breast patient with implanted breast in volumetric‐modulated arc therapy deep‐inspiration breath‐hold (VMAT DIBH) setup, in which the simulation body contour (green) is overlaid in the image fusion between the setup anterior–posterior (AP, pink) and planning digitally reconstructed radiograph (DRR, green) images. (a) A good arm alignment, (b) medially arm misalignment, and (c) laterally arm misalignment, as indicated by the arrows (pink and green). The planning tumor volume (PTV) (red) and local lymph nodes from planning computed tomography (CT) are also overlaid to the planning DRR, including axillary nodes level I (blue), II (yellow), and III (light blue), super clavicle node (gray), and internal mammary node (badge). The nodes within the PTV would be deformed and changed if the arm is away from the simulation position (green)
Comparison of vertical shift (with pitch rotation) difference between AlignRT and 2DkV for locally advanced breast DIBH SGRT patients treated with VMAT with a bolus in 25 patients, who had various breast conditions and were treated across the multi‐center clinics. The AlignRT setup was done first, followed by 2DkV, therefore, the 2DkV represent the difference from the AlignRT setup. The anterior surface distances at the inferior sternum from FB to DIBH are also listed, quantifying the surface shift in the anterior–posterior (AP) direction
|
|
|
|
| |||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
| 1 | 50 | Mastectomy | 1321 | −0.08 | 0.26 | −0.20 | 0.66 | 0.97 |
| 2 | 43 | Bilateral implant | 1631 | 0.10 | 0.42 | 0.20 | 1.28 | 0.46 |
| 3 | 56 | Intact, medium | 1086 | 0.04 | 0.19 | 0.52 | 0.80 | 1.70 |
| 4 | 59 | Bilateral implant | 1657 | −0.44 | 0.44 | −0.82 | 1.02 | 1.25 |
| 5 | 43 | Lt implant only | 1132 | −0.05 | 0.26 | 0.29 | 0.83 | 0.85 |
| 6 | 31 | Bilateral implant | 1733 | −0.35 | 0.75 | 0.44 | 1.11 | 1.18 |
| 7 | 36 | Bilateral implant | 2187 | −0.15 | 0.41 | −0.19 | 0.72 | 1.07 |
| 8 | 43 | Intact, pendulous | 2596 | −0.14 | 0.38 | −0.25 | 0.72 | 0.76 |
| 9 | 67 | Intact, large | 1974 | −0.22 | 0.31 | −0.01 | 0.24 | 1.78 |
| 10 | 34 | Bilateral implant | 1336 | −0.35 | 0.47 | −0.27 | 0.57 | 0.46 |
| 11 | 43 | Bilateral implant | 1317 | 0.03 | 0.27 | −0.17 | 0.51 | 1.55 |
| 12 | 49 | Mastectomy | 1140 | 0.03 | 0.27 | −0.17 | 0.51 | 0.81 |
| 13 | 53 | Bilateral implant | 2638 | −0.29 | 0.27 | 0.04 | 0.67 | 0.74 |
| 14 | 74 | Intact, small | 820 | −0.31 | 0.27 | 0.10 | 0.74 | 0.62 |
| 15 | 68 | Mastectomy | 1016 | −0.16 | 0.46 | −0.95 | 1.14 | 1.96 |
| 16 | 46 | Intact, large | 2419 | −0.08 | 0.36 | 0.05 | 0.18 | 1.46 |
| 17 | 38 | Bilateral implant | 1746 | −0.13 | 0.15 | −0.01 | 0.54 | 2.45 |
| 18 | 55 | Native, large | 2500 | −0.25 | 0.24 | −0.55 | 0.81 | 1.20 |
| 19 | 39 | Mastectomy | 2099 | 0.07 | 0.34 | 0.39 | 0.78 | 0.90 |
| 20 | 34 | Lt implant only | 1825 | −0.29 | 0.37 | −0.72 | 1.14 | 1.72 |
| 21 | 65 | Native, medium | 1639 | 0.01 | 0.38 | −0.69 | 0.39 | 1.55 |
| 22 | 38 | Native, large | 2448 | −0.28 | 0.16 | −0.05 | 1.00 | 1.51 |
| 23 | 55 | Mastectomy | 1012 | 0.08 | 0.66 | 0.07 | 1.05 | 1.08 |
| 24 | 36 | Bilat implant | 1886 | 0.22 | 0.40 | 0.03 | 0.03 | 0.55 |
| 25 | 40 | Mastectomy | 1583 | −0.13 | 0.37 | 0.54 | 0.74 | 0.94 |
| Average | 48 | 1710 | −0.13 | 0.35 | −0.10 | 0.72 | 1.18 | |
| St Dev | 12 | 544 | 0.17 | 0.14 | 0.41 | 0.32 | 0.51 | |
Notes: The PTV includes both breast tissue and local lymph nodes.
The large mean vertical shift is due to the pitch rotation that has a minor correlation with the vertical translation.
Abbreviations: DIBH, deep‐inspiration breath‐hold; FB, free‐breathing; SGRT, surface‐guided radiotherapy; VMAT, volumetric‐modulated arc therapy; PTV, planning tumor volume.